Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells
- PMID: 568163
- PMCID: PMC2184936
- DOI: 10.1084/jem.148.2.544
Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells
Abstract
Bacterial lipopolysaccharides (LPS) stimulate mouse peritoneal macrophages to kill tumor cells in vitro. Lysis is confined to tumor cells where it is nonspecific; both allogeneic and syngeneic cells being susceptible. Stimulation by LPS appears to be due to direct interaction between LPS and macrophages and does not involve participation by lymphocytes. After exposure to LPS, a latent period must elapse before macrophages can lyse tumor cells. The cytolytic mechanism requires contact between target cells and viable effector cells which maintain their lytic capacity for a sustained period and can kill on repeated occasions. The generation of a macrophage cytolytic effect by LPS is critically dependent upon the absolute number of macrophages which must be sufficient to produce confluent monolayers. These findings indicate that LPS stimulation of macrophages in vitro represents a valuable model system for the study of the mechanisms of macrophage stimulation and of the mediation of tumor cell death.
Similar articles
-
Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.Immunology. 1984 Jun;52(2):307-17. Immunology. 1984. PMID: 6735438 Free PMC article.
-
Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.J Immunol. 1991 Oct 15;147(8):2816-23. J Immunol. 1991. PMID: 1918995
-
In vitro activation of tumoricidal properties of rat peritoneal macrophages using lipopolysaccharide.Neoplasma. 1990;37(4):405-14. Neoplasma. 1990. PMID: 2234202
-
Tumoristatic effects of nonimmune BALB/c peritoneal macrophages on syngeneic lymphoma cells in vitro.Oncology. 1977;34(6):245-50. doi: 10.1159/000225234. Oncology. 1977. PMID: 593652
-
The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.J Reticuloendothel Soc. 1983 Mar;33(3):165-74. J Reticuloendothel Soc. 1983. PMID: 6834360
Cited by
-
Bacterial lipopolysaccharide suppresses the production of catalytically active lysosomal acid hydrolases in human macrophages.J Cell Biol. 1986 May;102(5):1606-14. doi: 10.1083/jcb.102.5.1606. J Cell Biol. 1986. PMID: 3700468 Free PMC article.
-
Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.J Exp Med. 1979 Jan 1;149(1):84-99. doi: 10.1084/jem.149.1.84. J Exp Med. 1979. PMID: 368287 Free PMC article.
-
Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.Immunology. 1984 Jun;52(2):307-17. Immunology. 1984. PMID: 6735438 Free PMC article.
-
Human alveolar macrophages: effects of endotoxin in vitro.Infect Immun. 1980 Dec;30(3):753-8. doi: 10.1128/iai.30.3.753-758.1980. Infect Immun. 1980. PMID: 7014447 Free PMC article.
-
Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes.Clin Exp Immunol. 1982 Apr;48(1):256-60. Clin Exp Immunol. 1982. PMID: 7200841 Free PMC article.
